Literature DB >> 24067552

Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.

Steven R Nesheim1, Felicia Hardnett, John T Wheeling, George K Siberry, Mary E Paul, Patricia Emmanuel, Beverly Bohannon, Kenneth Dominguez.   

Abstract

BACKGROUND: Little is known about immune reconstitution inflammatory syndrome in children in the United States.
METHODS: LEGACY is a longitudinal cohort study of HIV-infected participants 0-24 years at enrollment during 2005 to 2007 from 22 US clinics. For this analysis, we included participants with complete medical record abstraction from birth or time of HIV diagnosis through 2006. Opportunistic illness (OI) included AIDS-defining conditions and selected HIV-related diagnoses. We calculated the incidence (#/100 patient-years) of OI diagnosed in the months pre- and postinitiation of the first highly active antiretroviral therapy (HAART) regimen which was followed by ≥1 log reduction in HIV viral load. We defined OI as immune reconstitution inflammatory syndrome if an OI incidence increased after HAART initiation. "Responders" were defined as experiencing ≥1 log decline in viral load within 6 months after HAART initiation.
RESULTS: Among 575 patients with complete chart abstraction, 524 received HAART. Of these 524 patients, 343 were responders, 181 were nonresponders and 86 experienced OI. Responders accounted for 98 of 124 (79%) of OI. Pre-HAART and post-HAART OI incidences were 43.7 and 24.4 (P = 0.003), respectively, among responders and 15.9 and 9.1 (P = 0.2), respectively, among nonresponders. Overall, OI incidences among responders and nonresponders were 33.8 and 12.3, respectively (P = 0.002). Responders were more likely than nonresponders to experience herpes simplex and herpes zoster before HAART initiation (all, P < 0.002).
CONCLUSIONS: The lack of immune reconstitution inflammatory syndrome in participants initiating HAART may be due to low overall OI rates. The unexpectedly higher OI prevalence comprised mainly of herpes simplex and zoster, before HAART initiation among responders, may have motivated them to better adhere to HAART.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24067552      PMCID: PMC3785006          DOI: 10.1097/INF.0b013e31829ee893

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  28 in total

1.  Immune reconstitution inflammatory syndrome (IRIS) due to Bacille Calmette Guerin (BCG) in an HIV-positive child.

Authors:  A Kroidl; K Huck; S Weinspach; S Gudowius; C R Mackenzie; M Oette; D Häussinger; T Niehues
Journal:  Scand J Infect Dis       Date:  2006

2.  Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.

Authors:  Thanyawee Puthanakit; Linda Aurpibul; Peninnah Oberdorfer; Noppadon Akarathum; Suparat Kanjananit; Pornphun Wannarit; Thira Sirisanthana; Virat Sirisanthana
Journal:  Clin Infect Dis       Date:  2007-01-09       Impact factor: 9.079

3.  Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-05-28

4.  The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.

Authors:  Anneke C Hesseling; Ben J Marais; Robert P Gie; H Simon Schaaf; Paul E M Fine; Peter Godfrey-Faussett; Nulda Beyers
Journal:  Vaccine       Date:  2006-08-01       Impact factor: 3.641

5.  Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.

Authors:  Nutthapong Tangsinmankong; Wasu Kamchaisatian; Jorge Lujan-Zilbermann; Cynthia L Brown; John W Sleasman; Patricia J Emmanuel
Journal:  J Allergy Clin Immunol       Date:  2004-04       Impact factor: 10.793

6.  Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children.

Authors:  M Zampoli; T Kilborn; B Eley
Journal:  Int J Tuberc Lung Dis       Date:  2007-04       Impact factor: 2.373

7.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

8.  Immune reconstitution inflammatory syndrome in human immunodeficiency virus-infected children in Peru.

Authors:  Marie E Wang; Maria E Castillo; Silvia M Montano; Joseph R Zunt
Journal:  Pediatr Infect Dis J       Date:  2009-10       Impact factor: 2.129

9.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Mona Marin; Dalya Güris; Sandra S Chaves; Scott Schmid; Jane F Seward
Journal:  MMWR Recomm Rep       Date:  2007-06-22

10.  Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options.

Authors:  David M Murdoch; Willem D F Venter; Annelies Van Rie; Charles Feldman
Journal:  AIDS Res Ther       Date:  2007-05-08       Impact factor: 2.250

View more
  4 in total

1.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

2.  High Prevalence of Antibiotic-Resistant Otitis Media-Associated Bacterial Flora of Asymptomatic People Living with HIV at Morogoro Hospital, Tanzania.

Authors:  Kennedy Daniel Mwambete; Mathias Eulambius
Journal:  J Int Assoc Provid AIDS Care       Date:  2018 Jan-Dec

3.  Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.

Authors:  Sophie Desmonde; Anne M Neilan; Beverly Musick; Gabriela Patten; Kulkanya Chokephaibulkit; Andrew Edmonds; Stephany N Duda; Karen Malateste; Kara Wools-Kaloustian; Andrea L Ciaranello; Mary-Ann Davies; Valériane Leroy
Journal:  J Int AIDS Soc       Date:  2020-10       Impact factor: 5.396

4.  Assessment of liver disease by non-invasive methods in perinatally infected Brazilian adolescents and young adults living with Human Immunodeficiency Virus (HIV).

Authors:  Aida de Fátima Thomé Barbosa Gouvêa; Roberto Carvalho Filho; Daisy Maria Machado; Fabiana Bononi do Carmo; Suenia Vasconcelos Beltrão; Laurene Sampaio; Maria Isabel de Moraes-Pinto; Regina Célia de Menezes Succi
Journal:  Braz J Infect Dis       Date:  2021-06-18       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.